https://www.selleckchem.com/pr....oducts/emricasan-idn
97, P=0.03; and hazard ratio 0.95, P=0.02). The 5-year biochemical recurrence-free survival rates were (75.8% vs 65.9, P=0.09) and (54.1% vs 24.9%, P=0.023) for groupA and groupB in the overall cohort and pN-positive cohort, respectively. Indocyanine green-guided lymph node dissection plus extended pelvic lymph node dissection improves identification of lymphatic drainage, resulting in a higher number of lymph nodes and retrieved lymph node metastases, and allowing a more accurate local staging and a prolonged bio
Like
Comment
Share
